RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Tuesday reported a loss of $3.8 million in its fourth quarter.
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 14 cents.
The diagnostics company posted revenue of $6.8 million in the period.
For the year, the company reported that its loss narrowed to $20.4 million, or 75 cents per share. Revenue was reported as $27.5 million.
The company’s shares closed at 26 cents. A year ago, they were trading at 97 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX
Please read our comment policy before commenting.